Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1953 1
1972 1
1974 1
1985 2
1986 2
1987 2
1989 3
1990 4
1991 3
1993 1
1994 1
1995 3
1996 3
1997 2
1998 2
1999 5
2000 5
2001 5
2002 7
2003 6
2004 2
2005 11
2006 9
2007 15
2008 11
2009 12
2010 17
2011 17
2012 20
2013 22
2014 24
2015 30
2016 32
2017 34
2018 27
2019 45
2020 67
2021 69
2022 33
Text availability
Article attribute
Article type
Publication date

Search Results

484 results
Results by year
Filters applied: . Clear all
Page 1
Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial.
Lanzoni G, Linetsky E, Correa D, Messinger Cayetano S, Alvarez RA, Kouroupis D, Alvarez Gil A, Poggioli R, Ruiz P, Marttos AC, Hirani K, Bell CA, Kusack H, Rafkin L, Baidal D, Pastewski A, Gawri K, Leñero C, Mantero AMA, Metalonis SW, Wang X, Roque L, Masters B, Kenyon NS, Ginzburg E, Xu X, Tan J, Caplan AI, Glassberg MK, Alejandro R, Ricordi C. Lanzoni G, et al. Among authors: correa d. Stem Cells Transl Med. 2021 May;10(5):660-673. doi: 10.1002/sctm.20-0472. Epub 2021 Jan 5. Stem Cells Transl Med. 2021. PMID: 33400390 Free PMC article. Clinical Trial.
Landscape of cancer cell therapies: trends and real-world data.
Saez-Ibañez AR, Upadhaya S, Partridge T, Shah M, Correa D, Campbell J. Saez-Ibañez AR, et al. Among authors: correa d. Nat Rev Drug Discov. 2022 Sep;21(9):631-632. doi: 10.1038/d41573-022-00095-1. Nat Rev Drug Discov. 2022. PMID: 35650421 No abstract available.
R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma.
Omuro A, Correa DD, DeAngelis LM, Moskowitz CH, Matasar MJ, Kaley TJ, Gavrilovic IT, Nolan C, Pentsova E, Grommes CC, Panageas KS, Baser RE, Faivre G, Abrey LE, Sauter CS. Omuro A, et al. Among authors: correa dd. Blood. 2015 Feb 26;125(9):1403-10. doi: 10.1182/blood-2014-10-604561. Epub 2015 Jan 7. Blood. 2015. PMID: 25568347 Free PMC article. Clinical Trial.
The clinical pipeline for cancer cell therapies.
Upadhaya S, Yu JX, Shah M, Correa D, Partridge T, Campbell J. Upadhaya S, et al. Among authors: correa d. Nat Rev Drug Discov. 2021 Jul;20(7):503-504. doi: 10.1038/d41573-021-00100-z. Nat Rev Drug Discov. 2021. PMID: 34088999 No abstract available.
Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome.
Morris PG, Correa DD, Yahalom J, Raizer JJ, Schiff D, Grant B, Grimm S, Lai RK, Reiner AS, Panageas K, Karimi S, Curry R, Shah G, Abrey LE, DeAngelis LM, Omuro A. Morris PG, et al. Among authors: correa dd. J Clin Oncol. 2013 Nov 1;31(31):3971-9. doi: 10.1200/JCO.2013.50.4910. Epub 2013 Oct 7. J Clin Oncol. 2013. PMID: 24101038 Free PMC article. Clinical Trial.
In Response.
Correa D, Farney RJ, Chung F, Prasad A, Lam D, Wong J. Correa D, et al. Anesth Analg. 2016 Mar;122(3):915-916. doi: 10.1213/ANE.0000000000001034. Anesth Analg. 2016. PMID: 26891400 No abstract available.
Neurocognitive functions in primary CNS lymphoma.
Correa DD. Correa DD. Neuro Oncol. 2021 Aug 2;23(8):1220-1221. doi: 10.1093/neuonc/noab113. Neuro Oncol. 2021. PMID: 33984147 Free PMC article. No abstract available.
484 results